BioCentury
ARTICLE | Company News

Versicor, Novartis deal

November 20, 2000 8:00 AM UTC

VERS received a milestone payment from NOVN under the companies' 1999 deal for delivering an assay to identify bacterial deformylase inhibitor candidates. ...